-
1
-
-
0028128943
-
The oxidation hypothesis of atherosclerosis
-
Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 344, 793-795 (1994).
-
(1994)
Lancet
, vol.344
, pp. 793-795
-
-
Witztum, J.L.1
-
2
-
-
23944493587
-
Vitamin E, oxidative stress and inflammation
-
Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress and inflammation. Ann. Rev. Nutr. 25, 151-174 (2005).
-
(2005)
Ann. Rev. Nutr
, vol.25
, pp. 151-174
-
-
Singh, U.1
Devaraj, S.2
Jialal, I.3
-
3
-
-
26844564082
-
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
-
Johansen JS, Harris A, Rychly D, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Card. Diab. 4, 5-15 (2005).
-
(2005)
Card. Diab
, vol.4
, pp. 5-15
-
-
Johansen, J.S.1
Harris, A.2
Rychly, D.3
Ergul, A.4
-
4
-
-
33746383083
-
Common presence of non-transferrin bound iron among patients with Type II diabetes
-
Lee DH, Folsom AR, Harnack L, Halliwell B, Jacobs DR. Common presence of non-transferrin bound iron among patients with Type II diabetes. Diab. Care 29, 1090-1095 (2006).
-
(2006)
Diab. Care
, vol.29
, pp. 1090-1095
-
-
Lee, D.H.1
Folsom, A.R.2
Harnack, L.3
Halliwell, B.4
Jacobs, D.R.5
-
5
-
-
33646575616
-
Oxidative stress and diabetes associated complications
-
Ceriello PA. Oxidative stress and diabetes associated complications. Endo. Prac. 12, 60-62 (2006).
-
(2006)
Endo. Prac
, vol.12
, pp. 60-62
-
-
Ceriello, P.A.1
-
6
-
-
0032859788
-
Vitamin E and its function in membranes
-
Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog. Lipid Res. 38, 309-316 (1999).
-
(1999)
Prog. Lipid Res
, vol.38
, pp. 309-316
-
-
Wang, X.1
Quinn, P.J.2
-
7
-
-
0037840165
-
Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomized trials
-
Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet 361, 2017-2023 (2003).
-
(2003)
Lancet
, vol.361
, pp. 2017-2023
-
-
Vivekananthan, D.P.1
Penn, M.S.2
Sapp, S.K.3
Hsu, A.4
Topol, E.J.5
-
8
-
-
33646098696
-
Role of diabetes in atherosclerosis pathogenesis. What have we learned from animal models?
-
Renard C, Van Obberghen E. Role of diabetes in atherosclerosis pathogenesis. What have we learned from animal models? Diab. Metab. 32, 15-29 (2006).
-
(2006)
Diab. Metab
, vol.32
, pp. 15-29
-
-
Renard, C.1
Van Obberghen, E.2
-
9
-
-
24644498663
-
Development of atherosclerosis in the diabetic BALB/c mice. Prevention with vitamin E administration
-
Otero P, Bonet B, Herrera E, Rabano A. Development of atherosclerosis in the diabetic BALB/c mice. Prevention with vitamin E administration. Atherosclerosis 182, 259-265 (2005).
-
(2005)
Atherosclerosis
, vol.182
, pp. 259-265
-
-
Otero, P.1
Bonet, B.2
Herrera, E.3
Rabano, A.4
-
10
-
-
14944367546
-
Vitamin E and cardiovascular disease: Observational studies
-
Gaziano JM. Vitamin E and cardiovascular disease: observational studies. Ann. NY Acad. Sci. 1031, 280-291 (2004).
-
(2004)
Ann. NY Acad. Sci
, vol.1031
, pp. 280-291
-
-
Gaziano, J.M.1
-
11
-
-
4744368242
-
Vitamins to prevent cancer: Supplementary problems
-
Forman D, Altman D. Vitamins to prevent cancer: supplementary problems. Lancet 364, 1193-1194 (2004).
-
(2004)
Lancet
, vol.364
, pp. 1193-1194
-
-
Forman, D.1
Altman, D.2
-
12
-
-
19944427642
-
Meta-analysis: High dosage vitamin E supplementation may increase all cause mortality
-
Miller ER, Barriuso RP, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high dosage vitamin E supplementation may increase all cause mortality. Ann. Intern. Med. 142, 37-46 (2005).
-
(2005)
Ann. Intern. Med
, vol.142
, pp. 37-46
-
-
Miller, E.R.1
Barriuso, R.P.2
Dalal, D.3
Riemersma, R.A.4
Appel, L.J.5
Guallar, E.6
-
13
-
-
20044383911
-
Effects of long-term vitamin E supplementation on cardiovascular events and cancer
-
HOPE and HOPE-2 Trial Investigators
-
HOPE and HOPE-2 Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer. JAMA 293, 1338-1347 (2005).
-
(2005)
JAMA
, vol.293
, pp. 1338-1347
-
-
-
14
-
-
14844292725
-
Is there any hope for vitamin E?
-
Brown BG, Crowley J. Is there any hope for vitamin E? JAMA 293, 1387-1390 (2005).
-
(2005)
JAMA
, vol.293
, pp. 1387-1390
-
-
Brown, B.G.1
Crowley, J.2
-
15
-
-
0037197722
-
Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?
-
Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105, 2107-2111 (2002).
-
(2002)
Circulation
, vol.105
, pp. 2107-2111
-
-
Steinberg, D.1
Witztum, J.L.2
-
16
-
-
21444438990
-
Vitamin E in the primary prevention of cardiovascular disease and cancer: The Womens Health Study: a randomized controlled trial
-
Lee IM, Cook NR, Gaziano JM et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Womens Health Study: a randomized controlled trial. JAMA 294, 56-65 (2005).
-
(2005)
JAMA
, vol.294
, pp. 56-65
-
-
Lee, I.M.1
Cook, N.R.2
Gaziano, J.M.3
-
17
-
-
0035969564
-
Simvastatin and niacin, antioxidant vitamins or the combination for the prevention of coronary disease
-
Brown BG, Zhao XQ, Chait A et al. Simvastatin and niacin, antioxidant vitamins or the combination for the prevention of coronary disease. N. Engl. J. Med. 345, 1583-1592 (2001).
-
(2001)
N. Engl. J. Med
, vol.345
, pp. 1583-1592
-
-
Brown, B.G.1
Zhao, X.Q.2
Chait, A.3
-
18
-
-
0034688195
-
Vitamin E supplementation and cardiovascular events in high risk patients
-
HOPE Trial Investigators
-
HOPE Trial Investigators. Vitamin E supplementation and cardiovascular events in high risk patients. N. Engl. J. Med. 342, 154-161 (2000).
-
(2000)
N. Engl. J. Med
, vol.342
, pp. 154-161
-
-
-
19
-
-
0037031061
-
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high risk individuals; a randomized placebo controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high risk individuals; a randomized placebo controlled trial. Lancet 360, 7-22 (2002).
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
20
-
-
0034619027
-
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomized placebo controlled trial
-
Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo controlled trial. Lancet 356, 1213-1218 (2000).
-
(2000)
Lancet
, vol.356
, pp. 1213-1218
-
-
Boaz, M.1
Smetana, S.2
Weinstein, T.3
-
21
-
-
33646047815
-
Use of genomic signatures in therapeutics development in oncology and other diseases
-
Simon R, Wang SJ. Use of genomic signatures in therapeutics development in oncology and other diseases. Pharmacogenomics 6, 166-173 (2006).
-
(2006)
Pharmacogenomics
, vol.6
, pp. 166-173
-
-
Simon, R.1
Wang, S.J.2
-
22
-
-
17144460129
-
Haptoglobin: The evolutionary product of duplication, unequal crossing over, and point mutation
-
Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv. Hum. Genet. 12, 189-261 (1982).
-
(1982)
Adv. Hum. Genet
, vol.12
, pp. 189-261
-
-
Bowman, B.H.1
Kurosky, A.2
-
23
-
-
0037021557
-
Haptoglobin phenotype and the risk of cardiovascular disease in individuals with diabetes: The Strong Heart Study
-
Levy AP, Hochberg I, Jablonski K et al. Haptoglobin phenotype and the risk of cardiovascular disease in individuals with diabetes: the Strong Heart Study. J. Am. Coll. Card. 40, 1984-1990 (2002).
-
(2002)
J. Am. Coll. Card
, vol.40
, pp. 1984-1990
-
-
Levy, A.P.1
Hochberg, I.2
Jablonski, K.3
-
24
-
-
0042536434
-
Haptoglobin genotype is predictive of major adverse cardiac events in the one year period after PTCA in individuals with diabetes
-
Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP. Haptoglobin genotype is predictive of major adverse cardiac events in the one year period after PTCA in individuals with diabetes. Diab. Care 26, 2628-2631 (2003).
-
(2003)
Diab. Care
, vol.26
, pp. 2628-2631
-
-
Roguin, A.1
Koch, W.2
Kastrati, A.3
Aronson, D.4
Schomig, A.5
Levy, A.P.6
-
25
-
-
24144486972
-
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction
-
Suleiman M, Aronson D, Asleh R et al. Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes 19, 2802-2806 (2005).
-
(2005)
Diabetes
, vol.19
, pp. 2802-2806
-
-
Suleiman, M.1
Aronson, D.2
Asleh, R.3
-
26
-
-
33847671755
-
Haptoglobin genotype is a determinant of iron, lipid peroxidation and macrophage accumulation in the atherosclerotic plaque
-
Levy AP, Levy JE, Kalet-Litman S et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation and macrophage accumulation in the atherosclerotic plaque. Arterioscl. Thromb Vasc. Biol. 27, 1419-1425 (2007).
-
(2007)
Arterioscl. Thromb Vasc. Biol
, vol.27
, pp. 1419-1425
-
-
Levy, A.P.1
Levy, J.E.2
Kalet-Litman, S.3
-
27
-
-
33847217986
-
Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus
-
Miller-Lotan R, Miller B, Aronson D, Asaf R, Nakhoul F, Levy AP. Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus. Diab. Met. Res. Rev. 23, 152-156 (2007).
-
(2007)
Diab. Met. Res. Rev
, vol.23
, pp. 152-156
-
-
Miller-Lotan, R.1
Miller, B.2
Aronson, D.3
Asaf, R.4
Nakhoul, F.5
Levy, A.P.6
-
28
-
-
21744457960
-
Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus
-
Miller-Lotan R, Herskowitz Y, Kalet-Litman S et al. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus. Diab. Met. Res. Rev. 21, 332-337 (2005).
-
(2005)
Diab. Met. Res. Rev
, vol.21
, pp. 332-337
-
-
Miller-Lotan, R.1
Herskowitz, Y.2
Kalet-Litman, S.3
-
29
-
-
33845900436
-
Haptoglobin genotype determines myocardial infarct size in diabetic mice
-
Blum S, Asaf R, Guetta J et al. Haptoglobin genotype determines myocardial infarct size in diabetic mice. J. Am. Coll. Card. 49, 82-87 (2007).
-
(2007)
J. Am. Coll. Card
, vol.49
, pp. 82-87
-
-
Blum, S.1
Asaf, R.2
Guetta, J.3
-
30
-
-
33845665664
-
Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo
-
Asleh R, Miller-Lotan R, Aviram M et al. Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo. Circ. Res. 99, 1419-1425 (2006).
-
(2006)
Circ. Res
, vol.99
, pp. 1419-1425
-
-
Asleh, R.1
Miller-Lotan, R.2
Aviram, M.3
-
32
-
-
0035895080
-
Structure/function analysis of the anti-oxidant properties of haptoglobin
-
Frank M, Lache O, Enav B et al. Structure/function analysis of the anti-oxidant properties of haptoglobin. Blood 98, 3693-3698 (2001).
-
(2001)
Blood
, vol.98
, pp. 3693-3698
-
-
Frank, M.1
Lache, O.2
Enav, B.3
-
33
-
-
0030766447
-
Oxidation of low density lipoprotein by hemoglobin stems from a heme initiated globin radical: Antioxidant role of haptoglobin
-
Miller YI, Altamentova SM, Shaklai N. Oxidation of low density lipoprotein by hemoglobin stems from a heme initiated globin radical: antioxidant role of haptoglobin. Biochemistry 36, 12189-12198 (1997).
-
(1997)
Biochemistry
, vol.36
, pp. 12189-12198
-
-
Miller, Y.I.1
Altamentova, S.M.2
Shaklai, N.3
-
34
-
-
0016615657
-
The fate of circulating hemoglobin
-
Hershko C. The fate of circulating hemoglobin. Br. J. Hematol. 29, 199 (1975).
-
(1975)
Br. J. Hematol
, vol.29
, pp. 199
-
-
Hershko, C.1
-
35
-
-
0035843134
-
Identification of the hemoglobin scavenger receptor
-
Kristiansen M, Graversen JH, Jacobsen C et al. Identification of the hemoglobin scavenger receptor. Nature 409, 198-201 (2001).
-
(2001)
Nature
, vol.409
, pp. 198-201
-
-
Kristiansen, M.1
Graversen, J.H.2
Jacobsen, C.3
-
36
-
-
0036174088
-
CD163: A signal receptor scavenging haptoglobin hemoglobin complexes from plasma
-
Graversen JH, Madsen M, Moestrup SK. CD163: a signal receptor scavenging haptoglobin hemoglobin complexes from plasma. Int. J. Biochem. Cell Biol. 234, 309-314 (2002).
-
(2002)
Int. J. Biochem. Cell Biol
, vol.234
, pp. 309-314
-
-
Graversen, J.H.1
Madsen, M.2
Moestrup, S.K.3
-
38
-
-
14844345323
-
Haptoglobin genotype and diabetes dependent differences in iron mediated oxidative stress in vitro and in vivo
-
Asleh R, Guetta J, Kalet-Litman S, Miller-Lotan R, Levy AP. Haptoglobin genotype and diabetes dependent differences in iron mediated oxidative stress in vitro and in vivo. Circ. Res. 96, 435-441 (2005).
-
(2005)
Circ. Res
, vol.96
, pp. 435-441
-
-
Asleh, R.1
Guetta, J.2
Kalet-Litman, S.3
Miller-Lotan, R.4
Levy, A.P.5
-
39
-
-
0033955735
-
Advances in surface plasmon resonance biosensor analysis
-
Rich RL, Myszka DG. Advances in surface plasmon resonance biosensor analysis. Curr. Opin. Biotech. 11, 54-61 (2000).
-
(2000)
Curr. Opin. Biotech
, vol.11
, pp. 54-61
-
-
Rich, R.L.1
Myszka, D.G.2
-
40
-
-
1842539298
-
Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL
-
Bamm VV, Tsemakhovich VA, Shaklai M, Shaklai N. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43, 3899-3906 (2004).
-
(2004)
Biochemistry
, vol.43
, pp. 3899-3906
-
-
Bamm, V.V.1
Tsemakhovich, V.A.2
Shaklai, M.3
Shaklai, N.4
-
41
-
-
0038042030
-
Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease
-
Asleh R, Marsh S, Shiltruck M et al. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ. Res. 92, 1193-1200 (2003).
-
(2003)
Circ. Res
, vol.92
, pp. 1193-1200
-
-
Asleh, R.1
Marsh, S.2
Shiltruck, M.3
-
42
-
-
33646816714
-
Neovascularization in human atherosclerosis
-
Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation 113, 2245-2252 (2006).
-
(2006)
Circulation
, vol.113
, pp. 2245-2252
-
-
Moreno, P.R.1
Purushothaman, K.R.2
Sirol, M.3
Levy, A.P.4
Fuster, V.5
-
43
-
-
0037109184
-
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Role of oxidative stress
-
Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Role of oxidative stress. Circulation 106, 2067-2072 (2002).
-
(2002)
Circulation
, vol.106
, pp. 2067-2072
-
-
Esposito, K.1
Nappo, F.2
Marfella, R.3
-
44
-
-
0042393597
-
High glucose induced expression of proinflammatory cytokine and chemokine genes in monocytic cells
-
Shanmugam N, Reddy MA, Guha M, Natarajan R. High glucose induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52, 1256-1264 (2003).
-
(2003)
Diabetes
, vol.52
, pp. 1256-1264
-
-
Shanmugam, N.1
Reddy, M.A.2
Guha, M.3
Natarajan, R.4
-
45
-
-
7444241367
-
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes
-
Levy AP, Gerstein HC, Miller-Lotan R et al. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Diab. Care 27, 2767 (2004).
-
(2004)
Diab. Care
, vol.27
, pp. 2767
-
-
Levy, A.P.1
Gerstein, H.C.2
Miller-Lotan, R.3
|